Naproxen Sodium Tablet, Film Coated
Product Images NDC 58602-845

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Naproxen Sodium (NDC 58602-845). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aurohealth Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Package Label-principal Display Panel (220 mg (24 Tablets, Container Label))

Drug Facts panel for Naproxen Sodium Tablets, USP 220 mg (NSAID), film-coated tablets by Aurohealth LLC. Covers active ingredient information, pain reliever and fever reducer purposes, warnings for allergies and bleeding, directions for use in adults and children, and inactive ingredients. Includes allergy alert, heart attack and stroke warnings, overdose instructions, and contact information for questions or comments.*

FDA Label Image

Package Label-principal Display Panel (220 mg (24 Tablets Carton Label))

Naproxen Sodium 220 mg film-coated tablets carton label distributed by Aurohealth LLC. The label features dosage information, drug facts including uses, warnings, directions, and inactive ingredients. The packaging is marked for 100 tablets with a blue and yellow color scheme and includes barcodes, storage instructions, and contact information.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.